Stock Scorecard
Stock Summary for Illumina Inc (ILMN) - $99.31 as of 9/12/2025 3:43:14 PM EST
Total Score
8 out of 30
Safety Score
57 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ILMN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ILMN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ILMN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ILMN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ILMN (57 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 9 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ILMN
Financial Details for ILMN
Company Overview |
|
|---|---|
| Ticker | ILMN |
| Company Name | Illumina Inc |
| Country | USA |
| Description | Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. |
| Sector Name | HEALTHCARE |
| Industry Name | DIAGNOSTICS & RESEARCH |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/30/2025 |
Stock Price History |
|
| Last Day Price | 99.31 |
| Price 4 Years Ago | 370.08 |
| Last Day Price Updated | 9/12/2025 3:43:14 PM EST |
| Last Day Volume | 1,515,816 |
| Average Daily Volume | 1,628,389 |
| 52-Week High | 156.66 |
| 52-Week Low | 68.70 |
| Last Price to 52 Week Low | 44.56% |
Valuation Measures |
|
| Trailing PE | 12.04 |
| Industry PE | 39.68 |
| Sector PE | 40.86 |
| 5-Year Average PE | 80.72 |
| Free Cash Flow Ratio | 16.33 |
| Industry Free Cash Flow Ratio | 81.55 |
| Sector Free Cash Flow Ratio | 29.37 |
| Current Ratio Most Recent Quarter | 1.81 |
| Total Cash Per Share | 6.08 |
| Book Value Per Share Most Recent Quarter | 14.66 |
| Price to Book Ratio | 6.76 |
| Industry Price to Book Ratio | 244.23 |
| Sector Price to Book Ratio | 32.27 |
| Price to Sales Ratio Twelve Trailing Months | 3.41 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.38 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.72 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 153,700,000 |
| Market Capitalization | 15,263,947,000 |
| Institutional Ownership | 103.37% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.17% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -96.50% |
| Annual Earnings Growth | -5.34% |
| Reported EPS 12 Trailing Months | 7.90 |
| Reported EPS Past Year | 2.16 |
| Reported EPS Prior Year | 2.45 |
| Net Income Twelve Trailing Months | 1,258,000,000 |
| Net Income Past Year | -1,223,000,000 |
| Net Income Prior Year | -1,161,000,000 |
| Quarterly Revenue Growth YOY | -4.80% |
| 5-Year Revenue Growth | 4.29% |
| Operating Margin Twelve Trailing Months | 21.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 934,000,000 |
| Total Cash Past Year | 1,127,000,000 |
| Total Cash Prior Year | 1,048,000,000 |
| Net Cash Position Most Recent Quarter | -558,000,000 |
| Net Cash Position Past Year | -363,000,000 |
| Long Term Debt Past Year | 1,490,000,000 |
| Long Term Debt Prior Year | 1,489,000,000 |
| Total Debt Most Recent Quarter | 1,492,000,000 |
| Equity to Debt Ratio Past Year | 0.61 |
| Equity to Debt Ratio Most Recent Quarter | 0.64 |
| Total Stockholder Equity Past Year | 2,373,000,000 |
| Total Stockholder Equity Prior Year | 5,745,000,000 |
| Total Stockholder Equity Most Recent Quarter | 2,606,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,031,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 6.71 |
| Free Cash Flow Past Year | 709,000,000 |
| Free Cash Flow Prior Year | 283,000,000 |
Options |
|
| Put/Call Ratio | 0.68 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.37 |
| MACD Signal | -0.03 |
| 20-Day Bollinger Lower Band | 74.21 |
| 20-Day Bollinger Middle Band | 92.48 |
| 20-Day Bollinger Upper Band | 110.75 |
| Beta | 1.43 |
| RSI | 42.18 |
| 50-Day SMA | 108.54 |
| 150-Day SMA | 140.64 |
| 200-Day SMA | 173.68 |
System |
|
| Modified | 9/13/2025 2:08:43 AM EST |